218 related articles for article (PubMed ID: 17488481)
1. Selective inhibition of prostacyclin synthase activity by rofecoxib.
Griffoni C; Spisni E; Strillacci A; Toni M; Bachschmid MM; Tomasi V
J Cell Mol Med; 2007; 11(2):327-38. PubMed ID: 17488481
[TBL] [Abstract][Full Text] [Related]
2. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
[TBL] [Abstract][Full Text] [Related]
3. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
4. Double-label expression studies of prostacyclin synthase, thromboxane synthase and COX isoforms in normal aortic endothelium.
Kawka DW; Ouellet M; Hétu PO; Singer II; Riendeau D
Biochim Biophys Acta; 2007 Jan; 1771(1):45-54. PubMed ID: 17189713
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
[TBL] [Abstract][Full Text] [Related]
6. Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer.
Shyue SK; Tsai MJ; Liou JY; Willerson JT; Wu KK
Circulation; 2001 Apr; 103(16):2090-5. PubMed ID: 11319200
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-inflammatory activity of omega-3 lipid and rofecoxib pretreatment on macrophage proinflammatory cytokine production occurs via divergent NF-kappaB activation.
Babcock TA; Helton WS; Anwar KN; Zhao YY; Espat NJ
JPEN J Parenter Enteral Nutr; 2004; 28(4):232-9; discussion 239-40. PubMed ID: 15291404
[TBL] [Abstract][Full Text] [Related]
8. Cyclic strain is a weak inducer of prostacyclin synthase expression in bovine aortic endothelial cells.
Segurola RJ; Oluwole B; Mills I; Yokoyama C; Tanabe T; Kito H; Nakajima N; Sumpio BE
J Surg Res; 1997 Apr; 69(1):135-8. PubMed ID: 9202659
[TBL] [Abstract][Full Text] [Related]
9. Curcumin potentiates the anti-inflammatory activity of cyclooxygenase inhibitors in the cotton pellet granuloma pouch model.
Nandal S; Dhir A; Kuhad A; Sharma S; Chopra K
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):89-93. PubMed ID: 19455263
[TBL] [Abstract][Full Text] [Related]
10. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}.
Sobrino A; Oviedo PJ; Novella S; Laguna-Fernandez A; Bueno C; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
J Mol Endocrinol; 2010 Apr; 44(4):237-46. PubMed ID: 20110403
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin Synthase as an Ambivalent Regulator of Inflammatory Reactions.
Ochiai T; Honsawa T; Sasaki Y; Hara S
Biol Pharm Bull; 2022; 45(8):979-984. PubMed ID: 35908907
[TBL] [Abstract][Full Text] [Related]
12. COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.
Voloshyna I; Kasselman LJ; Carsons SE; Littlefield MJ; Gomolin IH; De Leon J; Reiss AB
J Investig Med; 2017 Mar; 65(3):694-704. PubMed ID: 27940550
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
[TBL] [Abstract][Full Text] [Related]
14. Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells.
Liou JY; Shyue SK; Tsai MJ; Chung CL; Chu KY; Wu KK
J Biol Chem; 2000 May; 275(20):15314-20. PubMed ID: 10809766
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men.
Tuleja E; Mejza F; Cmiel A; Szczeklik A
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1111-5. PubMed ID: 12730088
[TBL] [Abstract][Full Text] [Related]
16. Colocalization prostacyclin (PGI2) synthase--caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis.
Spisni E; Griffoni C; Santi S; Riccio M; Marulli R; Bartolini G; Toni M; Ullrich V; Tomasi V
Exp Cell Res; 2001 May; 266(1):31-43. PubMed ID: 11339822
[TBL] [Abstract][Full Text] [Related]
17. Role of prostacyclin synthase in carcinogenesis.
Sasaki Y; Ochiai T; Takamura M; Kondo Y; Yokoyama C; Hara S
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():49-52. PubMed ID: 28506876
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy.
Camacho M; Piñeiro Z; Alcolea S; García J; Balart J; Terra X; Avilés-Jurado FX; Soler M; Quer M; León X; Vila L
J Pathol; 2015 Jan; 235(1):125-35. PubMed ID: 25256272
[TBL] [Abstract][Full Text] [Related]
19. Beraprost sodium protects against chronic brain injury in aluminum-overload rats.
Pan Y; Yu L; Lei W; Guo Y; Wang J; Yu H; Tang Y; Yang J
Behav Brain Funct; 2015 Feb; 11(1):6. PubMed ID: 25888780
[TBL] [Abstract][Full Text] [Related]
20. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Wang M; Song WL; Cheng Y; Fitzgerald GA
J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
